The Latest Breaking News from Medtronic

With longevity science booming, you might make it to age 150. We separate the hype from proven strategies. Because the "science is extremely promising."

Medtronic is on track to complete a market reversal later this year as investments in technology and innovation begin to pay off.

Medtronic (MDT) and Zimmer Biomet (ZBH) are emerging as serious contenders in robotic surgery, challenging Intuitive Surgical’s (ISRG) market dominance.

The medtech market is thriving, thanks to the increasing investments and surging demand for enhanced efficiency. Therefore, investors could benefit from these trends by investing in fundamentally solid medical device stocks Becton, Dickinson and Company (BDX), Medtronic (MDT), and Abbott Laboratories (ABT), which are revolutionizing patient care. Keep reading.

Although Medtronic has lagged behind the broader S&P 500 index over the past three months, analysts remain moderately optimistic about the stock’s prospects.

The Dividend Aristocrats offer reliable yields; buying them when they are down provides a lever for total returns and a vehicle for market-beating returns.

Medtronic's stock price is in a classic head-and-shoulders reversal that could take it back to record highs within the next two years.

December S&P 500 E-Mini futures (ESZ24) are down -0.40%, and December Nasdaq 100 E-Mini futures (NQZ24) are down -0.32% this morning as risk sentiment took a hit after Russian President Vladimir Putin updated the country’s nuclear doctrine, while investors awaited fresh data on the U.S. housing market and an earnings…

All eyes are on NVDA this week in a highly anticipated earnings report. We also have a few other big names all set to report such as Walmart, Snowflake, Target, Lowe’s, Palo Alto Networks, Deere & Company and Medtronic.